Published in Br J Pharmacol on March 01, 2002
Analgesic efficacy of CR4056, a novel imidazoline-2 receptor ligand, in rat models of inflammatory and neuropathic pain. J Pain Res (2011) 1.08
Alpha 2A-adrenergic receptor signaling underlies synergistic enhancement of ethanol-induced behavioral impairment by clonidine. Alcohol Clin Exp Res (2008) 0.82
Excitatory regulation of noradrenergic neurons by L-arginine/nitric oxide pathway in the rat locus coeruleus in vivo. Naunyn Schmiedebergs Arch Pharmacol (2007) 0.77
The Effect of Intra-CA1 Agmatine Microinjection on Water Maze Learning and Memory in Rat. Iran Red Crescent Med J (2011) 0.76
Interactions of nitric oxide with α2 -adrenoceptors within the locus coeruleus underlie the facilitation of inhibitory avoidance memory by agmatine. Br J Pharmacol (2016) 0.75
Pharmacological estimation of drug-receptor dissociation constants. Statistical evaluation. I. Agonists. J Pharmacol Exp Ther (1971) 4.23
Agmatine: an endogenous clonidine-displacing substance in the brain. Science (1994) 2.83
Selective inhibitors of neuronal nitric oxide synthase--is no NOS really good NOS for the nervous system? Trends Pharmacol Sci (1997) 1.92
Is agmatine a novel neurotransmitter in brain? Trends Pharmacol Sci (2000) 1.39
'Seeing through a glass darkly': casting light on imidazoline 'I' sites. Trends Pharmacol Sci (1998) 1.37
Inhibition of mammalian nitric oxide synthases by agmatine, an endogenous polyamine formed by decarboxylation of arginine. Biochem J (1996) 1.24
Noradrenergic neurons of the locus coeruleus: inhibition by epinephrine and activation by the alpha-antagonist piperoxane. Brain Res (1976) 1.17
Activation of I(2)-imidazoline receptors enhances supraspinal morphine analgesia in mice: a model to detect agonist and antagonist activities at these receptors. Br J Pharmacol (2000) 1.16
Comparison of the properties of agmatine and endogenous clonidine-displacing substance at imidazoline and alpha-2 adrenergic receptors. J Pharmacol Exp Ther (1995) 1.14
Regional localization of agmatine in the rat brain: an immunocytochemical study. Brain Res (1998) 1.06
Biological significance of agmatine, an endogenous ligand at imidazoline binding sites. Br J Pharmacol (2001) 1.04
Determination of agmatine in brain and plasma using high-performance liquid chromatography with fluorescence detection. J Chromatogr B Biomed Sci Appl (1997) 1.03
Agmatine containing axon terminals in rat hippocampus form synapses on pyramidal cells. Neurosci Lett (1998) 1.01
Localization of adenylyl and guanylyl cyclase in rat brain by in situ hybridization: comparison with calmodulin mRNA distribution. J Neurosci (1992) 0.98
Modulation of opioid analgesia by agmatine. Eur J Pharmacol (1996) 0.98
Agmatinase activity in rat brain: a metabolic pathway for the degradation of agmatine. J Neurochem (1996) 0.98
Stimulatory effects of clonidine, cirazoline and rilmenidine on locus coeruleus noradrenergic neurones: possible involvement of imidazoline-preferring receptors. Naunyn Schmiedebergs Arch Pharmacol (1993) 0.98
Selective inhibition of inducible nitric oxide synthase by agmatine. Jpn J Pharmacol (1995) 0.97
Molecular characterization of a type II cyclic GMP-dependent protein kinase expressed in the rat brain. J Neurochem (1995) 0.91
Agmatine, a novel hypothalamic amine, stimulates pituitary luteinizing hormone release in vivo and hypothalamic luteinizing hormone-releasing hormone release in vitro. Neurosci Lett (1995) 0.90
Agmatine enhances the NADPH oxidase activity of neuronal NO synthase and leads to oxidative inactivation of the enzyme. Mol Pharmacol (2001) 0.90
Inhibitory effect of agmatine on naloxone-precipitated abstinence syndrome in morphine dependent rats. Life Sci (1997) 0.88
Uptake of agmatine into rat brain synaptosomes: possible role of cation channels. J Neurochem (1997) 0.88
Nitric oxide and carbon monoxide activate locus coeruleus neurons through a cGMP-dependent protein kinase: involvement of a nonselective cationic channel. J Neurosci (1996) 0.88
Agmatine activation of nitric oxide synthase in endothelial cells. Proc Assoc Am Physicians (1997) 0.87
A functional role for nitric oxide in locus coeruleus: immunohistochemical and electrophysiological studies. Exp Brain Res (1994) 0.87
Agmatine affects glomerular filtration via a nitric oxide synthase-dependent mechanism. Am J Physiol (1997) 0.87
Regulation of locus coeruleus neurons and splanchnic, sympathetic nerves by cardiovascular afferents. Brain Res (1984) 0.84
Biological effects of arginine metabolites. Acta Physiol Scand (2000) 0.84
N omega-hydroxyagmatine: a novel substance causing endothelium-dependent vasorelaxation. Biochem Biophys Res Commun (1995) 0.83
Agmatine does not have activity at alpha 2-adrenoceptors which modulate the firing rate of locus coeruleus neurones: an electrophysiological study in rat. Neurosci Lett (1996) 0.83
The stimulatory effect of clonidine on locus coeruleus neurons of rats with inactivated alpha 2-adrenoceptors: involvement of imidazoline receptors located in the nucleus paragigantocellularis. Naunyn Schmiedebergs Arch Pharmacol (1997) 0.82
Stimulation of locus coeruleus neurons by non-I1/I2-type imidazoline receptors: an in vivo and in vitro electrophysiological study. Br J Pharmacol (1998) 0.80
Dual interaction of agmatine with the rat alpha(2D)-adrenoceptor: competitive antagonism and allosteric activation. Br J Pharmacol (2000) 0.78
The stimulatory effect of clonidine through imidazoline receptors on locus coeruleus noradrenergic neurones is mediated by excitatory amino acids and modulated by serotonin. Naunyn Schmiedebergs Arch Pharmacol (1995) 0.77
Modulation of anxiety-like behavior and morphine dependence in CREB-deficient mice. Neuropsychopharmacology (2004) 1.24
Locus coeruleus and dorsal raphe neuron activity and response to acute antidepressant administration in a rat model of Parkinson's disease. Int J Neuropsychopharmacol (2010) 0.88
Attenuation of acute and chronic effects of morphine by the imidazoline receptor ligand 2-(2-benzofuranyl)-2-imidazoline in rat locus coeruleus neurons. Br J Pharmacol (2003) 0.88
Systemic effect of cannabinoids on the spontaneous firing rate of locus coeruleus neurons in rats. Eur J Pharmacol (2006) 0.87
Inhibition of neuronal nitric oxide synthase attenuates the development of morphine tolerance in rats. Synapse (2005) 0.85
The locus coeruleus is directly implicated in L-DOPA-induced dyskinesia in parkinsonian rats: an electrophysiological and behavioural study. PLoS One (2011) 0.85
Effect of the CB(1) receptor antagonists rimonabant and AM251 on the firing rate of dorsal raphe nucleus neurons in rat brain slices. Br J Pharmacol (2009) 0.83
Cannabinoids enhance N-methyl-D-aspartate-induced excitation of locus coeruleus neurons by CB1 receptors in rat brain slices. Neurosci Lett (2004) 0.82
CB(1) cannabinoid receptors inhibit the glutamatergic component of KCl-evoked excitation of locus coeruleus neurons in rat brain slices. Neuropharmacology (2006) 0.82
Long-term survival of encapsulated GDNF secreting cells implanted within the striatum of parkinsonized rats. Int J Pharm (2007) 0.82
Regulation of central noradrenergic activity by 5-HT(3) receptors located in the locus coeruleus of the rat. Neuropharmacology (2012) 0.81
Glutamate-induced post-activation inhibition of locus coeruleus neurons is mediated by AMPA/kainate receptors and sodium-dependent potassium currents. Br J Pharmacol (2009) 0.81
In vivo administration of VEGF- and GDNF-releasing biodegradable polymeric microspheres in a severe lesion model of Parkinson's disease. Eur J Pharm Biopharm (2013) 0.79
Nigrostriatal denervation changes the effect of cannabinoids on subthalamic neuronal activity in rats. Psychopharmacology (Berl) (2010) 0.78
Short-term effects of 3,4-methylenedioximethamphetamine on noradrenergic activity in locus coeruleus and hippocampus of the rat. Neurosci Lett (2003) 0.78
Role of GIRK channels on the noradrenergic transmission in vivo: an electrophysiological and neurochemical study on GIRK2 mutant mice. Int J Neuropsychopharmacol (2012) 0.78
Comparative study of the effects of desipramine and reboxetine on locus coeruleus neurons in rat brain slices. Neuropharmacology (2004) 0.77
Electrophysiological characterization of substantia nigra dopaminergic neurons in partially lesioned rats: effects of subthalamotomy and levodopa treatment. Brain Res (2006) 0.77
Excitatory regulation of noradrenergic neurons by L-arginine/nitric oxide pathway in the rat locus coeruleus in vivo. Naunyn Schmiedebergs Arch Pharmacol (2007) 0.77
Regulation of subthalamic neuron activity by endocannabinoids. Synapse (2010) 0.77
Endocannabinoid modulation of dopaminergic motor circuits. Front Pharmacol (2012) 0.77
Two opposite effects of Delta(9)-tetrahydrocannabinol on subthalamic nucleus neuron activity: involvement of GABAergic and glutamatergic neurotransmission. Synapse (2010) 0.77
alpha(2)-Adrenoceptor involvement in the in vitro inhibitory effect of citalopram on a subpopulation of rat locus coeruleus neurons. Eur J Pharmacol (2005) 0.76
In vivo effect of tramadol on locus coeruleus neurons is mediated by alpha2-adrenoceptors and modulated by serotonin. Neuropharmacology (2006) 0.76
Morphine withdrawal is modified in pituitary adenylate cyclase-activating polypeptide type I-receptor-deficient mice. Brain Res Mol Brain Res (2003) 0.76
The role of the subthalamic nucleus in L-DOPA induced dyskinesia in 6-hydroxydopamine lesioned rats. PLoS One (2012) 0.76
Effect of ceftriaxone and topiramate treatments on naltrexone-precipitated morphine withdrawal and glutamate receptor desensitization in the rat locus coeruleus. Psychopharmacology (Berl) (2015) 0.75
Increased opioid dependence in a mouse model of panic disorder. Front Behav Neurosci (2010) 0.75
Agmatine-morphine interaction on nociception in mice. Ann N Y Acad Sci (2003) 0.75
Acute and long-term administration of citalopram desensitizes alpha2-adrenoceptors in the rat vas deferens. J Pharm Pharmacol (2006) 0.75